Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Jim Cramer - Mad MoneyPerkinElmerPKIWATCHAug 08, 2022

He recommends it, but has had a rough year. It did good business during Covid, mostly in Covid testing. But this created tough comparisons. Last Tuesday, they reported a modest revenue beat and stronger earnings beat, plus gave encouraging full-year guidance. They're restructuring. See what they say after earnings on Thursday.
$154.09

Stock price when the opinion was issued

$99.66

As of Jun 12, 2026. Market Open.

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.